Cargando…

Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia

MLL rearrangement (MLLr) is responsible for the development of acute leukemias with poor outcomes. Therefore, new therapeutic approaches are urgently needed. The NOTCH1 pathway plays a critical role in the pathogenesis of many cancers including acute leukemia. Using a CRISPR/Cas9 MLL-AF4/-AF9 transl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fischer, Jacqueline, Erkner, Estelle, Fitzel, Rahel, Radszuweit, Pia, Keppeler, Hildegard, Korkmaz, Fulya, Roti, Giovanni, Lengerke, Claudia, Schneidawind, Dominik, Schneidawind, Corina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572120/ https://www.ncbi.nlm.nih.gov/pubmed/37833915 http://dx.doi.org/10.3390/ijms241914466

Ejemplares similares

Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity
por: Fitzel, Rahel, et al.
Publicado: (2023)

Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by MLL-AF4 Translocations
por: Secker, Kathy-Ann, et al.
Publicado: (2020)

PB1803: SMAD1 IS A TUMOR SUPPRESSOR IN ACUTE MYELOID LEUKEMIA WITH MLL REARRANGEMENT
por: Dietsche, Lisa, et al.
Publicado: (2023)

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia
por: Schmid, Hannes, et al.
Publicado: (2018)

MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis
por: Secker, Kathy-Ann, et al.
Publicado: (2020)

Inhibition of effector B cells by ibrutinib in systemic sclerosis
por: Einhaus, Jakob, et al.
Publicado: (2020)

Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cells
por: Schmid, Hannes, et al.
Publicado: (2021)

Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis
por: Pecher, Ann-Christin, et al.
Publicado: (2019)

Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote ex vivo Lysis of Leukemic Blasts in a CD1d-Dependent Manner
por: Jahnke, Simona, et al.
Publicado: (2019)

Editorial: Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
por: Schneidawind, Dominik, et al.
Publicado: (2020)

Replication stress in MLL-rearrangements
por: Milyavsky, Michael, et al.
Publicado: (2015)

Erratum: Replication stress in MLL-rearrangements
por: Milyavsky, Michael, et al.
Publicado: (2016)

A Fibrinogen Alpha Fragment Mitigates Chemotherapy-Induced MLL Rearrangements
por: Eberle, Julia, et al.
Publicado: (2021)

RNA binding proteins in MLL-rearranged leukemia
por: Tran, Tiffany M., et al.
Publicado: (2022)

Haploidentical transplant with posttransplant cyclophosphamide vs matched related and unrelated donor transplant in acute myeloid leukemia and myelodysplastic neoplasm
por: Rieger, Max J., et al.
Publicado: (2023)

MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
por: Zangrando, Andrea, et al.
Publicado: (2009)

Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia
por: van der Linden, Marieke H., et al.
Publicado: (2015)

PAFc, a Key Player in MLL-rearranged Leukemogenesis
por: Tan, Jiaying, et al.
Publicado: (2010)

MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches
por: Winters, Amanda C., et al.
Publicado: (2017)

Molecular pathogenesis of disease progression in MLL-rearranged AML
por: Kotani, Shinichi, et al.
Publicado: (2018)

Initiation of MLL-rearranged AML is dependent on C/EBPα
por: Ohlsson, Ewa, et al.
Publicado: (2014)

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
por: Feng, Zizhen, et al.
Publicado: (2016)

MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations
por: Kerstjens, Mark, et al.
Publicado: (2016)

DOT1L Inhibition Sensitizes MLL-Rearranged AML to Chemotherapy
por: Liu, Wei, et al.
Publicado: (2014)

The landscape of somatic mutations in Infant MLL rearranged acute lymphoblastic leukemias
por: Andersson, Anna K, et al.
Publicado: (2015)

The developmental stage of the hematopoietic niche regulates lineage in MLL-rearranged leukemia
por: Rowe, R. Grant, et al.
Publicado: (2019)

Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia
por: Hurtz, Christian, et al.
Publicado: (2019)

Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
por: Brzezinka, Krzysztof, et al.
Publicado: (2019)

Role of Lymphocyte Activation Gene-3 (Lag-3) in Conventional and Regulatory T Cell Function in Allogeneic Transplantation
por: Sega, Emanuela I., et al.
Publicado: (2014)

The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viability
por: Grey, William, et al.
Publicado: (2018)

Targeting Notch Trafficking and Processing in Cancers
por: Pagliaro, Luca, et al.
Publicado: (2020)

Coexistence of treatment-related MLL cleavage and rearrangement in a child with haemophagocytic lymphohistiocytosis
por: Ng, A, et al.
Publicado: (2004)

MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals
por: Brassesco, María Sol, et al.
Publicado: (2009)

ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia
por: Germano, Giuseppe, et al.
Publicado: (2017)

Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
por: Chan, Anthony K. N., et al.
Publicado: (2019)

Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged Leukemia
por: Barve, Aditya, et al.
Publicado: (2019)

Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia
por: Oliveira, Tiago, et al.
Publicado: (2021)

PROM1 and CTGF Expression in Childhood MLL-Rearrangement Acute Lymphoblastic Leukemia
por: Wang, Lu-lu, et al.
Publicado: (2022)

The MLL–Menin Interaction is a Therapeutic Vulnerability in NUP98-rearranged AML
por: Rasouli, Milad, et al.
Publicado: (2023)

Targeting oncogenic Notch signaling with SERCA inhibitors
por: Pagliaro, Luca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o41k0hnm8dj89k3lc1t21qnmoe